메뉴 건너뛰기
Neurology
Volumn 70, Issue 13, 2008, Pages 988-989
Dyslipidemia in ALS: Good, bad, or unclear?
Author keywords

[No Author keywords available]
Indexed keywords

HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; UBIDECARENONE;
EID: 41349105143     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000306636.61882.42     Document Type: Editorial
Times cited : (3)
References (7)
  • 1
    • 3343020674 scopus 로고    scopus 로고
    • Evidence for defective energy homeostasis in amyotrophic laterals sclerosis: benefit of a high-energy diet in a transgenic mouse model.
    • Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic laterals sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 2004;101:11159-11164.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 11159-11164
    • Dupuis, L.1    Oudart, H.2    Rene, F.3    Gonzalez de Aguilar, J.L.4    Loeffler, J.P.5
  • 2
    • 41349122697 scopus 로고    scopus 로고
    • Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
    • Dupuis L, Corcia P, Fergani A, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2007;70:1004-1009.
    • (2007) Neurology , vol.70 , pp. 1004-1009
    • Dupuis, L.1    Corcia, P.2    Fergani, A.3
  • 3
    • 34249902026 scopus 로고    scopus 로고
    • Statins, neuromuscular degenerative disease, and an amyotrophic lateral sclerosis-like syndrome: an analysis of Individual Case safety Reports from Vigibase.
    • Edwards IR, Star K, Kiuru A. Statins, neuromuscular degenerative disease, and an amyotrophic lateral sclerosis-like syndrome: an analysis of Individual Case safety Reports from Vigibase. Drug Safety 2007;30:515-525.
    • (2007) Drug Safety , vol.30 , pp. 515-525
    • Edwards, I.R.1    Star, K.2    Kiuru, A.3
  • 4
    • 34248207189 scopus 로고    scopus 로고
    • Coenzyme Q treatment of neurodegenerative diseases of aging.
    • Galpern WR, Cudkowitz ME. Coenzyme Q treatment of neurodegenerative diseases of aging. Mitochondrion 2007;7(suppl 1):S146-153.
    • (2007) Mitochondrion , vol.7
    • Galpern, W.R.1    Cudkowitz, M.E.2
  • 5
    • 0030042365 scopus 로고    scopus 로고
    • Nutritional status of patients with amyotrophic lateral sclerosis: relation to proximity of death.
    • Kasarkis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to proximity of death. Am J Clin Nutr 1996;63:130-137.
    • (1996) Am J Clin Nutr , vol.63 , pp. 130-137
    • Kasarkis, E.J.1    Berryman, S.2    Vanderleest, J.G.3    Schneider, A.R.4    McClain, C.J.5
  • 6
    • 18044366164 scopus 로고    scopus 로고
    • The metabolic hypothesis in amyotrophic lateral sclerosis: Insights from mutant Cu/Zn-superoxide dismutase mice.
    • Gonzalez de Aguilar JL, Dupois L, Oudart H, Loeffler JP. The metabolic hypothesis in amyotrophic lateral sclerosis: Insights from mutant Cu/Zn-superoxide dismutase mice. Biomed Pharmacother 2005;59:190-196.
    • (2005) Biomed Pharmacother , vol.59 , pp. 190-196
    • Gonzalez de Aguilar, J.L.1    Dupois, L.2    Oudart, H.3    Loeffler, J.P.4
  • 7
    • 0036525567 scopus 로고    scopus 로고
    • Coenzyme Q10 as a possible treatment for neurodegenerative diseases.
    • Beal MF. Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radical Res 2002;36:455-460.
    • (2002) Free Radical Res , vol.36 , pp. 455-460
    • Beal, M.F.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.